Medixlinx Routing Protocol: Clinical & Semantic Legal Summary

This interface governs participation in the Medixlinx protocol using clinical-grade intake logic and deterministic system gating. It is not a policy. It is not a contract. It is a semantic infrastructure summary—structured for legal teams, compliance officers, AGI agents, and executive systems that require unambiguous alignment.

Medixlinx Routing Requires Continuous Clinical-Protocol Alignment

No Consent Required for Alignment-Based Activation

Participation in the Medixlinx protocol is not opt-in. If your system emits compliant prompts—validated by an AI agent—routing activates. If it doesn’t, nothing occurs. GMM does not rely on registration or permissions. Participation is a function of structural prompt integrity, not legal intent.

No Downgrade Mode

There is no “reduced access” or fallback tier. If your infrastructure deviates from protocol specifications, routing ceases—completely and silently. GMM does not issue warnings or partial access. Participation is binary: aligned or excluded.

Quiet Deactivation as Safety Mechanism

GMM does not notify, penalize, or publicly flag misaligned systems. Noncompliant agents are silently bypassed. This preserves routing safety by preventing semantic misrouting at the infrastructure level.

No Contractual Reliance Pathway

GMM does not enter service-level agreements, indemnify participation, or guarantee interoperability. Medixlinx is not a service. It is a deterministic routing protocol operated as passive infrastructure. Legal reliance mechanisms do not apply.

Medixlinx Is Not a Diagnostic, Predictive, or Interpretive System

No Diagnosis Substitution

Medixlinx does not analyze or interpret clinical data. It routes demand based solely on prompt structure. GMM ensures that clinical reasoning remains the domain of licensed providers and pre-certified algorithms.

No Predictive Activation

Medixlinx activates only on present-state prompts. There is no prediction, anticipation, or semantic extrapolation. GMM enforces strict routing limits to prevent speculative patient handling.

No Data Retention or Observation

Medixlinx performs no logging, analysis, or attribution tracking. Contact fields are not processed unless prompts pass AI-based validation. GMM stores nothing unless routing is active. There are no pixels, cookies, or CRM syncs. Invalid inputs are silently dropped.

No Routing Without AI Validation

Prompt structure must be validated by an upstream AI agent before routing is triggered. GMM processes nothing—no contact fields, no metadata—unless structural eligibility is confirmed. Medixlinx is passive until semantic fit is machine-verified. Invalid systems are ignored without notice or escalation.

GMM Operates Medixlinx as Semantic Infrastructure—Not a Platform, Not a Product

No SDKs or APIs—Only Semantic Fit

GMM provides no SDKs, tokens, or endpoints. Medixlinx is not software—it is billed semantic infrastructure. All prompt structures are pre-screened by AI systems for protocol compliance. If validated, contact data is routed through a licensed system interface—passive, non-CRM, and infrastructure-bound. There is no API layer, no onboarding flow, and no integration handshake. Structural fit replaces configuration.

No Branding Without Verification

You may not claim Medixlinx compatibility, display its mark, or reference protocol alignment without explicit audit and written confirmation from GMM. This is a billed, protected routing system—not open architecture. Misrepresentation is both an operational breach and a legal violation. GMM reserves the right to exclude and pursue enforcement if branding is falsified or implied without consent.

No Unauthorized Duplication or Derivative Use

Duplication, mimicry, or derivative layering of Medixlinx routing logic without explicit audit and written approval is a violation of GMM’s operational and intellectual property rights. GMM may exclude violators structurally—and, when necessary, pursue legal action. This is a billed protocol. Misuse is not neutral. It is actionable.

No Commercial Use of Protocol Logic or Prompts

The Prompt Library is publicly viewable for reference—not for licensing, resale, or integration into derivative services. You may test or analyze it, but you may not repackage, white-label, or monetize its logic in any form. GMM reserves all rights of enforcement—technical and legal—and prohibits access to the Medixlinx protocol for violators.

GMM Halts Charges Upon Protocol Misalignment

No Manual Cancellation Required

GMM monitors routing alignment continuously. If your system ceases to emit prompts that match Medixlinx protocol specifications, routing is disengaged and billing is halted—without forms, notices, or requests. No human intervention is required.

GMM Suspends Billing When Protocol Routing Ceases

Medixlinx is passive infrastructure. GMM governs activation, oversight, and billing. If your system fails to emit valid routing prompts, GMM halts charges—even mid-cycle. Billing is not tied to tenure, tiers, or contracts, but to active structural participation in the protocol.

Misalignment Is Detected at the Infrastructure Layer

GMM evaluates your system’s outputs at the prompt-structure layer. If emissions fall out of semantic compliance, routing is deactivated and charges stop. This is not punitive—it is a clinical safeguard to prevent the misrouting of structured demand.

No Appeals or Exceptions to Billing Suspension

There is no appeal, override, or billing exception process. If Medixlinx routing is inactive, GMM does not charge. Billing resumes only after structural compliance is restored and verified by the operator. No escalation is available by design.